COVID-19 Vaccination in India to Stretch To Late 2022

COVID-19 vaccination programme in India will stretch to late 2022, suggested a new study. Most developing countries will not have widespread access to the shots before 2023 at the earliest.

COVID-19 vaccination programme in India will stretch to late 2022, suggested a new study. Similar will be the scenario for most middle-income countries, including China, said the report by the Economist Intelligence Unit, the research division of the Economist Group.

While vaccination programme currently underway have raised hope of beating the pandemic, unequal distribution of vaccines, along with production issues, has become a major pain point.

COVID-19 Vaccination in India: Issues and Challenges
India’s COVID-19 vaccination program has been launched. It currently uses the vaccines Covishield and Covaxin. There are some issues and challenges that need to be overcome in order to vaccinate all Indians.

‘In India, the COVID-19 vaccination programme for most of the population will continue until mid-2022. ’

UN Secretary General Antonio Guterres on Wednesday reiterated his call for equitable access to Covid-19 vaccines as the global caseload has surpassed the 100 million mark, another grim milestone as the pandemic rages on.

"Most developing countries will not have widespread access to the shots before 2023 at the earliest," Agathe Demarais, Director of the Economist Intelligence Unit, said in its study on Wednesday.

"Some of these countries - particularly poorer ones with a young demographic profile - may well lose the motivation to distribute vaccines, especially if the disease has spread widely or if the associated costs prove too high."

COVID-19: Diet Plan and Lifestyle Modifications for the Unlock Phase
Healthy eating habits and adherence to physical activity are required during COVID-19 lockdown. WHO has prepared a set of general tips that you could follow during the lockdown to stay fit and healthy.

The study showed that more than 85 poor countries will not have widespread access to Covid-19 vaccines before 2023.

The research noted that Russia and China are trying to bolster their global status through vaccine diplomacy.

US Pharma Giant Merck Stops Development Of Two Potential Covid-19 Vaccines
Merck & Co, the US pharmaceutical giant has announced that it is discontinuing development of its Covid-19 vaccine candidates -- V590 and V591 -- after they failed to generate immune responses.

While the UK, the US and most countries in the European Union are likely to achieve the goal of vaccinating their priority groups by end of March, other rich countries are expected to achieve the same by end of June.

Therefore, the global economic recovery is expected to gain more momentum from the middle of this year.

UK Becomes First to Use Digital Ledgers to Monitor COVID-19 Vaccines
Two British hospitals are one of the first to use blockchain technology to monitor the supply and storage of COVID-19 vaccines.

Source-IANS